Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

The excised ILM from 7 eyes of 7 patients with MTM including 7 eyes with macular retinoschisis and 4 eyes with foveal detachment but without any retinal break underwent vitrectomy with induction of posterior vitreous detachment and ILM peeling was examined to evaluate ultrastructure with electron microscopy.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02528045` - Vitrectomy and Scleral Shortening for Macular Hole Retinal Detachment or Myopic Traction Maculopathy	N/A
	Completed	`NCT04278079` - Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy	N/A

NCT number	NCT02528058
Study type	Observational
Source	Kyorin University
Contact
Status	Completed
Phase	N/A
Start date	June 2010
Completion date	July 2015

Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of Highly Myopia With Myopic Traction Maculopathy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms